Medicine & Life Sciences
Bile Acids and Salts
100%
Glucagon-Like Peptide 1
89%
Type 2 Diabetes Mellitus
86%
Glucagon-Like Peptide-1 Receptor
72%
Sevelamer
70%
Colesevelam Hydrochloride
64%
Glucose
63%
Metformin
61%
Liraglutide
59%
Gallbladder Emptying
42%
rGLP-1 protein
40%
Placebos
38%
Exenatide
30%
Cholecystokinin
29%
Pharmacokinetics
26%
Safety
25%
imeglimin
24%
Glucagon-Like Peptide 2
23%
Therapeutics
21%
Clinical Trials
21%
Hormones
20%
Insulin
20%
Gallbladder
20%
Meals
16%
zinc-binding protein
16%
Sodium-Glucose Transporter 2 Inhibitors
16%
Insulin Secretion
15%
Network Meta-Analysis
14%
Pharmaceutical Preparations
14%
Equivalence Trials
14%
Insulin-Secreting Cells
13%
semaglutide
13%
Hunger
13%
Clinical Pharmacology
13%
Cross-Over Studies
12%
Gastric Bypass
12%
G-Protein-Coupled Receptors
12%
Gastric Emptying
11%
Gastrectomy
11%
Thyroxine
11%
Hypothyroidism
11%
8-hydroxyguanosine
11%
Nucleic Acids
10%
Zinc
10%
Diarrhea
10%
Type 1 Diabetes Mellitus
9%
Phosphates
9%
Eating
9%
Area Under Curve
9%
Glycated Hemoglobin A
9%
Chemistry
Metformin
36%
Albiglutide
26%
Colesevelam
26%
Glucagon-Like Peptide 1
19%
Insulin Derivative
17%
Bile Acid
16%
Cell Viability
11%
Pharmacokinetics
9%
Glucose
9%
Additive
7%
Glycemic
5%
Glucagon
5%
Plasma
5%